Literature DB >> 32092372

Comparison of daily dosing versus Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma and basal cell nevus syndrome: A retrospective case series.

Christina Wong1, Christine Poblete-Lopez2, Allison Vidimos2.   

Abstract

Entities:  

Year:  2020        PMID： 32092372     DOI： 10.1016/j.jaad.2020.02.050

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  1 in total

Review 1.  Long-Term Management of Advanced Basal Cell Carcinoma: Current Challenges and Future Perspectives.

Authors:  Markus V Heppt; Christoffer Gebhardt; Jessica C Hassel; Mareike Alter; Ralf Gutzmer; Ulrike Leiter; Carola Berking
Journal:  Cancers (Basel)       Date:  2022-09-20       Impact factor: 6.575
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.